Macular Pigment and Its Contribution to Visual Performance in the Older Human Eye

Macular Pigment and Its Contribution to Visual Performance in the Older Human Eye

Macular pigment and its contribution to visual performance in the older human eye A thesis submitted to the University of Manchester for the degree of a Doctor of Philosophy in the Faculty of Life Sciences 2014 Laura Patryas Optometry Contents 1 Introduction 19 1.1 Impact of ageing on the anatomy and physiology of the visual system . 20 1.1.1 The pupil . 22 1.1.2 The crystalline lens . 23 1.1.3 The retina . 24 1.1.4 Rods and cones . 26 1.1.5 Retinal pigment epithelium . 28 1.1.6 The interphotoreceptor matrix . 29 1.1.7 Bruch’s membrane . 30 1.1.8 Choriocapillaris and choroid . 30 1.2 Psychophysical function in ageing . 31 1.2.1 Spatial vision . 31 1.2.1.1 Visual acuity . 31 1.2.1.2 Contrast sensitivity . 32 1.2.2 Temporal vision . 33 1.2.3 Visual adaptation . 33 1.2.3.1 Dark adaptation . 33 1.2.3.2 Glare recovery . 36 1.3 Environmental factors in ageing . 37 1.3.1 Smoking . 38 1.3.2 Alcohol . 39 1.3.3 Radiation exposure . 39 1.3.4 Physical activity . 41 1.4 Ageing and age-related macular degeneration . 41 2 The macular pigment 43 2.1 Bio- and stereochemistry of macular pigment . 43 2.2 Location of macular pigment . 44 2 2.3 The function of macular pigment . 46 2.3.1 The potential role of macular pigment in normal healthy eyes . 49 2.4 Characteristics of macular pigment . 50 2.4.1 Composition . 50 2.4.2 Distribution . 50 2.4.3 Spatial profile . 52 2.4.4 Density and assimilation . 53 2.5 Factors affecting macular pigment density . 54 2.5.1 Age . 54 2.5.2 Gender . 54 2.5.3 Ocular factors . 55 2.5.3.1 Iris pigmentation . 55 2.5.3.2 Crystalline lens optical density . 55 2.5.4 Non-ocular factors . 55 2.5.4.1 Nutrition . 55 2.5.4.2 Smoking . 58 2.5.4.3 Obesity . 58 2.5.4.4 Light exposure . 58 2.5.4.5 Heredity . 59 2.5.4.6 Cultural differences in nutrition . 59 2.5.4.7 Ethnicity . 59 2.6 From plant to supplement . 59 2.6.1 Xanthophyll extraction . 59 2.6.2 Supplement preparation . 60 2.6.3 Recommended dosage . 60 2.6.4 Supplement safety . 60 2.7 Nutritional augmentation of macular pigment . 61 2.7.1 Supplementation studies in healthy eyes . 61 2.7.1.1 Effect on visual function . 62 3 2.7.2 Supplementation studies in ocular disease . 65 2.8 Bioavailability of macular pigment . 68 2.8.1 Dietary factors . 68 2.8.2 Supplement type . 69 2.8.3 Non-dietary factors . 69 2.9 Measurement of macular pigment . 71 3 Development of methods 73 3.1 Dark adaptation . 73 3.1.1 Introduction . 73 3.1.1.1 Retinal disease and dark adaptation . 76 3.1.1.2 General health and dark adaptation . 77 3.1.1.3 Photochemistry . 79 3.1.2 Study apparatus . 82 3.1.3 Calculating the percentage bleach . 83 3.1.4 Procedure . 84 3.1.5 Correcting data for pre-retinal absorption . 86 3.1.6 Modeling of dark adaptation data . 87 3.2 Factors affecting dark adaptation parameters: experimental data . 89 3.2.1 Bleach intensity . 89 3.2.2 Bleach frequency . 91 3.2.3 Pupil dilation . 92 3.2.4 Flash position . 94 3.2.5 Stimulus size in the periphery: rod spatial summation . 95 3.2.6 Stimulus location . 97 3.2.7 Summary . 98 3.3 Macular pigment apparatus . 99 3.3.1 Procedure . 99 3.3.2 MPOD calculation . 101 4 3.3.3 Repeatability . 102 3.4 Study design and protocol . 102 3.4.1 Pilot study . 102 3.4.1.1 Study design . 102 3.4.1.2 Study protocol . 103 3.4.1.3 Objectives . 103 3.4.1.4 Selection of study population . 103 3.4.1.5 Inclusion criteria . 103 3.4.1.6 Exclusion criteria . 104 3.4.1.7 Ethical conduct of the study . 105 3.4.1.8 Patient information sheet . 105 3.4.1.9 Study procedure and visit schedule . 106 3.4.1.10 Statistical analysis . 106 3.4.2 Supplementation study . 106 3.4.2.1 Study design . 106 3.4.2.2 Study protocol . 107 3.4.2.3 Objectives . 107 3.4.2.4 Selection of study population . 107 3.4.2.5 Inclusion criteria . 108 3.4.2.6 Exclusion criteria . 108 3.4.2.7 Ethical conduct of the study . 109 3.4.2.8 Patient information sheet . 109 3.4.2.9 Study procedure and visit schedule . 109 3.4.2.10 Study formulation and randomisation . 110 3.4.2.11 Active and placebo tablet formulation . 111 3.4.2.12 Dispensation and randomisation . 113 3.4.2.13 Directions for use . 113 3.4.2.14 Compliance . 113 3.4.2.15 Sample size calculation . 114 3.4.2.16 Statistical analysis . 115 3.4.2.17 Study protocol alterations . 115 5 4 Assessment of age changes and repeatability for computer based rod dark adaptation 116 4.1 Abstract . 117 4.1.1 Purpose............................... 117 4.1.2 Methods.............................. 117 4.1.3 Results............................... 117 4.1.4 Conclusions............................. 117 4.2 Introduction . 118 4.3 Methods . 119 4.3.1 Subjects . 119 4.3.2 Procedure . 120 4.3.3 Data analysis . 122 4.4 Results . 123 4.4.1 Preliminary data . 123 4.4.2 Repeatability . 124 4.4.3 Dark adaptation in older and younger eyes . 125 4.5 Discussion . 127 4.6 References . 129 5 The association between dark adaptation and macular pigment optical density in healthy subjects 132 5.1 Abstract . 133 5.1.1 Purpose . 133 5.1.2 Methods . 133 5.1.3 Results . 133 5.1.4 Conclusions . ..

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    245 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us